Nasr, I. N., A. A. A. Sallam, A. A. Abd El-Khair, E. A. M. Abd-Alla, A. F. Sayed, N. S. Ahmed, F. H. Abd-Rabo, A. E. Abou-Dawood, N. S. Ahmed, and F. A. M. Hassan,
"Organochlorine pesticide residues in cows milk and butter in Mexico.",
Journal of Applied Sciences, vol. 7, issue 20: orgz, pp. 243-248, 1991.
Abstractn/a
Philip, G., M. M. El Aref, M. Darwish, and S. Ewais,
"Paleoerosion Surfaces and Karst Manifestations Including "Egyptian Alabaster" in Gabal Hom-ret Schaibun - Gabal Sannur Area, East of the Nile Valley, Egypt. ",
Egypt. J. Geol., vol. 34, issue 1&2, pp. 41 -79, 1991.
Philip, G., M. M. El Aref, M. Darwish, and S. Ewais,
"Paleoerosion Surfaces and Karst Manifestations Including "Egyptian Alabaster" in Gabal Hom-ret Schaibun - Gabal Sannur Area, East of the Nile Valley, Egypt. ",
Egypt. J. Geol., vol. 34, issue 1&2, pp. 41 -79, 1991.
EI-Sergany, M. A., A. A. Morsy, E. I. - S. M. O. El-Sawy, and A.M.,
"Pathological effect of Senecio plant in chickens.",
Egyp. J. Comp. Path. C!in. Path., vol. 4, no. 1, pp. 150, 1991.
Abstractn/a
Atef, M., M. A. M. Abo-Norage, M. S. M. Hanafy, and A. E. Agag,
"Pharmacotoxicological aspects of nitrate and nitrite in domestic fowls",
British poultry science, vol. 32, no. 2: Taylor & Francis, pp. 399–404, 1991.
Abstractn/a
el Mawla, N. G., M. R. Hamza, A. el Khodari, H. Khaled, R. Gaafar, H. el Zawahry, A. abdel Wareth, M. D. Dardir, and N. Habboubi,
"A phase II study of epirubicin in breast cancer.",
Anti-cancer drugs, vol. 2, no. 4, pp. 371-374, 1991.
AbstractWe evaluated the efficacy of epirubicin in a phase II trial in breast cancer, as well as its cardiac toxicity. The study was carried out on 40 female patients with advanced, metastatic, or recurrent breast cancer. The patients were grouped into two groups: group I received 30 mg/m2 epirubicin weekly, and group II 90 mg/m2 epirubicin every 3 weeks. Cardiac monitoring was by ECG, roentgenography, echocardiography and endomyocardial biopsies. Clinical results were 35.3% overall response in group I, and 50% overall response in group II. No untoward cardiac toxicities were encountered. We conclude that epirubicin is an effective agent in breast cancer with relatively little cardiac toxicity.